Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moriya Tsuji

Showing results (31-40 of 121) with videos related to

Pageof 13
Sort By:
BMC Immunology|January 26, 2013
Effects of HIV-1-induced CD1c and CD1d modulation and endogenous lipid presentation on CD1c-restricted T-cell activationHalonna Kelly, Rajakumar Mandraju, Jordana G A Coelho-dos-Reis, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 13, 2005
Glycolipid presentation to natural killer T cells differs in an organ-dependent fashionJohn Schmieg, Guangli Yang, Richard W Franck, et al.
Immunology|June 3, 2009
Identification of C-glycoside analogues that display a potent biological activity against murine and human invariant natural killer T cellsXiangming Li, Guangwu Chen, Raquel Garcia-Navarro, et al.
Plos One|October 31, 2012
Peripheral blood invariant natural killer T cells of pig-tailed macaquesXiangming Li, Patricia Polacino, Raquel Garcia-Navarro, et al.
Vaccine|May 10, 2017
Co-localization of a CD1d-binding glycolipid with an adenovirus-based malaria vaccine for a potent adjuvant effectXiangming Li, Jing Huang, Akira Kawamura, et al.
Vaccine|November 2, 2017
A potent malaria vaccine based on adenovirus with dual modifications at Hexon and pVIITakayuki Shiratsuchi, Urvashi Rai, Izumi Kaneko, et al.
Expert Review of Vaccines|November 2, 2016
A potent adjuvant effect of a CD1d-binding NKT cell ligand in human immune system miceXiangming Li, Jing Huang, Izumi Kaneko, et al.
International Immunology|August 19, 2007
Function of NKT cells, potential anti-HIV effector cells, are improved by beginning HAART during acute HIV-1 infectionSandhya Vasan, Michael A Poles, Amir Horowitz, et al.
Journal of the American Chemical Society|July 13, 2006
Structure-based discovery of glycolipids for CD1d-mediated NKT cell activation: tuning the adjuvant versus immunosuppression activityMasakazu Fujio, Douglass Wu, Raquel Garcia-Navarro, et al.
Organic & Biomolecular Chemistry|February 22, 2017
Synthesis of C6''-modified α-C-GalCer analogues as mouse and human iNKT cell agonistsJoren Guillaume, Toshiyuki Seki, Tine Decruy, et al.
Pageof 13

Showing results (31-40 of 121) with videos related to

Sort By:
Pageof 13
BMC Immunology|January 26, 2013
Effects of HIV-1-induced CD1c and CD1d modulation and endogenous lipid presentation on CD1c-restricted T-cell activationHalonna Kelly, Rajakumar Mandraju, Jordana G A Coelho-dos-Reis, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 13, 2005
Glycolipid presentation to natural killer T cells differs in an organ-dependent fashionJohn Schmieg, Guangli Yang, Richard W Franck, et al.
Immunology|June 3, 2009
Identification of C-glycoside analogues that display a potent biological activity against murine and human invariant natural killer T cellsXiangming Li, Guangwu Chen, Raquel Garcia-Navarro, et al.
Plos One|October 31, 2012
Peripheral blood invariant natural killer T cells of pig-tailed macaquesXiangming Li, Patricia Polacino, Raquel Garcia-Navarro, et al.
Vaccine|May 10, 2017
Co-localization of a CD1d-binding glycolipid with an adenovirus-based malaria vaccine for a potent adjuvant effectXiangming Li, Jing Huang, Akira Kawamura, et al.
Vaccine|November 2, 2017
A potent malaria vaccine based on adenovirus with dual modifications at Hexon and pVIITakayuki Shiratsuchi, Urvashi Rai, Izumi Kaneko, et al.
Expert Review of Vaccines|November 2, 2016
A potent adjuvant effect of a CD1d-binding NKT cell ligand in human immune system miceXiangming Li, Jing Huang, Izumi Kaneko, et al.
International Immunology|August 19, 2007
Function of NKT cells, potential anti-HIV effector cells, are improved by beginning HAART during acute HIV-1 infectionSandhya Vasan, Michael A Poles, Amir Horowitz, et al.
Journal of the American Chemical Society|July 13, 2006
Structure-based discovery of glycolipids for CD1d-mediated NKT cell activation: tuning the adjuvant versus immunosuppression activityMasakazu Fujio, Douglass Wu, Raquel Garcia-Navarro, et al.
Organic & Biomolecular Chemistry|February 22, 2017
Synthesis of C6''-modified α-C-GalCer analogues as mouse and human iNKT cell agonistsJoren Guillaume, Toshiyuki Seki, Tine Decruy, et al.
Pageof 13